Hims & Hers Health Inc
HIMS58.400USD
+3.500+6.38%
Close 09/26, 16:00（ET）Quotes delayed by 15 min
13.18BMarket Cap
68.10P/E TTM
More Details of Company
Company Info
Ticker SymbolHIMS
Company nameHims & Hers Health Inc
IPO dateSep 09, 2019
CEOMr. Andrew Dudum
Number of employees1637
Security typeOrdinary Share
Fiscal year-endSep 09
Address2269 Chestnut St
CitySAN FRANCISCO
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94123
Phone14158510195
Websitehttps://www.forhims.com/
Ticker SymbolHIMS
IPO dateSep 09, 2019
CEOMr. Andrew Dudum
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.43M
+0.06%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
166.40K
+10.60%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
112.20K
-9.23%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+72.64%
Mr. Nader Kabbani
Mr. Nader Kabbani
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Mo Elshenawy
Mr. Mo Elshenawy
Chief Technology Officer
Chief Technology Officer
--
--
Mr. David Wells
Mr. David Wells
Lead Independent Director
Lead Independent Director
--
--
Dr. Delos Cosgrove, M.D.
Dr. Delos Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher D. Payne
Mr. Christopher D. Payne
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Dudum
Mr. Andrew Dudum
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
9.43M
+0.06%
Ms. Soleil Boughton
Ms. Soleil Boughton
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
166.40K
+10.60%
Mr. Oluyemi Okupe
Mr. Oluyemi Okupe
Chief Financial Officer
Chief Financial Officer
112.20K
-9.23%
Ms. Christiane Pendarvis
Ms. Christiane Pendarvis
Independent Director
Independent Director
36.56K
+37.31%
Mr. Kare Schultz
Mr. Kare Schultz
Independent Director
Independent Director
15.74K
+72.64%
Mr. Nader Kabbani
Mr. Nader Kabbani
Chief Operating Officer
Chief Operating Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Online
576.36M
98.35%
Wholesale
9.65M
1.65%
By RegionUSD
Name
Revenue
Proportion
United States
586.01M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Online
576.36M
98.35%
Wholesale
9.65M
1.65%
Shareholding Stats
Updated: Sun, Aug 17
Updated: Sun, Aug 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
9.96%
The Vanguard Group, Inc.
8.56%
Capital World Investors
8.53%
Capital Research Global Investors
6.79%
Dudum (Andrew)
4.33%
Other
61.83%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
9.96%
The Vanguard Group, Inc.
8.56%
Capital World Investors
8.53%
Capital Research Global Investors
6.79%
Dudum (Andrew)
4.33%
Other
61.83%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.43%
Investment Advisor/Hedge Fund
15.09%
Hedge Fund
12.21%
Individual Investor
10.67%
Research Firm
9.55%
Pension Fund
1.53%
Sovereign Wealth Fund
0.75%
Bank and Trust
0.64%
Venture Capital
0.40%
Other
0.73%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
893
201.00M
92.37%
-34.62M
2025Q1
847
185.19M
85.97%
-48.88M
2024Q4
739
195.19M
91.41%
-9.62M
2024Q3
627
167.49M
80.36%
-35.34M
2024Q2
588
165.89M
79.48%
-12.74M
2024Q1
503
156.70M
75.98%
-10.05M
2023Q4
463
153.90M
75.37%
-26.71M
2023Q3
444
160.41M
78.97%
-33.55M
2023Q2
426
173.15M
85.66%
-3.29M
2023Q1
404
156.26M
77.80%
-6.84M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
21.80M
10.12%
-5.83M
-21.10%
Mar 31, 2025
The Vanguard Group, Inc.
18.44M
8.56%
-1.78M
-8.80%
Mar 31, 2025
Dudum (Andrew)
10.23M
4.75%
+5.79K
+0.06%
Jun 17, 2025
Abraham (Jack)
9.32M
4.33%
-2.62M
-21.93%
Dec 31, 2023
Farallon Capital Management, L.L.C.
7.95M
3.69%
-423.30K
-5.05%
Mar 31, 2025
Goldman Sachs & Company, Inc.
7.72M
3.58%
+2.53M
+48.65%
Mar 31, 2025
State Street Global Advisors (US)
7.44M
3.45%
-329.75K
-4.24%
Mar 31, 2025
Renaissance Technologies LLC
7.02M
3.26%
+73.20K
+1.05%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
SPDR S&P Health Care Services ETF
1.49%
Janus Henderson Small Cap Growth Alpha ETF
0.95%
Global X Millennial Consumer ETF
0.84%
SEI Select Small Cap ETF
0.75%
JPMorgan Fundamental Data Science Small Core ETF
0.52%
ProShares Hedge Replication ETF
0.49%
ProShares UltraPro Russell2000
0.49%
Proshares Ultra Russell 2000
0.49%
RiverNorth Patriot ETF
0.44%
NYLI Candriam US Mid Cap Equity ETF
0.38%
View more
SPDR S&P Health Care Services ETF
Proportion1.49%
Janus Henderson Small Cap Growth Alpha ETF
Proportion0.95%
Global X Millennial Consumer ETF
Proportion0.84%
SEI Select Small Cap ETF
Proportion0.75%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.52%
ProShares Hedge Replication ETF
Proportion0.49%
ProShares UltraPro Russell2000
Proportion0.49%
Proshares Ultra Russell 2000
Proportion0.49%
RiverNorth Patriot ETF
Proportion0.44%
NYLI Candriam US Mid Cap Equity ETF
Proportion0.38%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
